Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

15.69USD
3:25pm GMT
Change (% chg)

$-0.04 (-0.25%)
Prev Close
$15.73
Open
$15.59
Day's High
$15.69
Day's Low
$15.16
Volume
24,908
Avg. Vol
232,175
52-wk High
$35.99
52-wk Low
$15.16

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $1,116.97
Shares Outstanding(Mil.): 36.11
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.33 -- --
ROI: -17.54 9.01 14.96
ROE: -22.51 10.15 16.52

Earnings vs. Estimates